How did cyclosporine improve the success of organ transplantation?

Cyclosporine significantly improved the success of organ transplantation by acting as a powerful immunosuppressive agent that specifically targets T lymphocytes. By inhibiting these white blood cells—which are responsible for attacking and eliminating foreign molecules—the drug effectively prevents the body from rejecting transplanted organs.12

The introduction of cyclosporine led to marked improvements in graft survival rates. For instance, many medical centers have achieved one-year survival rates of approximately 96 percent and five-year rates of about 80 percent for patients receiving kidneys from unrelated cadaver donors.3

Despite its efficacy, cyclosporine is a complex medication to manage. Because it is fat-soluble, its absorption varies between individuals, requiring careful monitoring to ensure dosages are adequate without becoming toxic, as the drug can cause permanent renal damage. Consequently, it is often used in combination with other agents, such as glucocorticoids, to optimize results while minimizing risks. Ongoing medical advancements continue to refine these therapies, including the development of nontoxic analogues of cyclosporine to further enhance patient outcomes.12